| March 18, 2005
Abramson Cancer Center of the
University of Pennsylvania Hosts Second Annual
Focus on Melanoma Conference
Thursday, March 31, 2005
12:30 PM – 4:30 PM
University of Pennsylvania Biomedical Research Building
II/III
Ground Floor Auditorium
Curie Boulevard & Osler Way, Philadelphia, PA
1-800-789-PENN
(Philadelphia, PA) A history of three or more sunburns
before age 20 – particularly severe, blistering
sunburns – may double your risk of melanoma, a
very serious form of skin cancer that causes the most
skin cancer-related deaths in the United States. According
to the American Cancer Society, melanoma is currently
the fastest growing cancer in the U.S., with incident
rates more than doubling since 1973. The good new is
that melanoma is highly curable if detected and treated
early.
On Thursday, March 31st from 12:30 – 4:30 p.m.,
the Abramson Cancer Center of the University
of Pennsylvania will host its second annual
Focus on Melanoma Educational Conference for
those whose lives have been affected by melanoma and
all who are looking to learn more about the prevention,
detection and treatment of this increasingly more common
cancer.
This education conference features presentations and
workshops led by faculty of the Abramson Cancer Center
and covers a full spectrum of topics from “Understanding
Melanoma,” “Safe Sun Strategies,”
to “Taking Control of Your Care,” “Enhancing
Your Quality of Life,” and learning how to find
the best melanoma information on the Internet.
Lynn Schuchter, MD, Associate Professor
of Medicine, Hematology/Oncology and Abramson Cancer
Center melanoma expert, is chairing the conference.
Currently, Dr. Schuchter participates in several national,
multi-site vaccine trials for melanoma. She is a leading
researcher in the study of the medication Gleevec™,
in combination with chemotherapy, for the treatment
of advanced melanoma.
Keynote speaker for the conference is Martin, C. Mihm,
JR, MD, FACP, Clinical Professor of Pathology and Dermatology
at the Harvard Medical School. A nationally recognized
researcher and clinician, Dr. Mihm’s work focuses
on the biology and pathology of malignant melanoma and
the immune reaction.
Refreshments and special exhibits will be provided for
conference guests. Admission is free. To register, please
call 1-800-789-PENN or register online at www.oncolink.org/conference.melanoma.
For
a printer friendly version of this release,
click
here.
###
The Abramson Cancer Center of the University
of Pennsylvania was established in
1973 as a center of excellence in cancer research, patient
care, education and outreach. Today, the Abramson Cancer
Center ranks as one of the nation’s best in cancer
care, according to U.S. News & World Report, and
is one of the top five in National Cancer Institute
(NCI) funding. It is one of only 39 NCI-designated comprehensive
cancer centers in the United States. Home to one of
the largest clinical and research programs in the world,
the Abramson Cancer Center of the University of Pennsylvania
has 275 active cancer researchers and 250 Penn physicians
involved in cancer prevention, diagnosis and treatment.
PENN Medicine is a $2.7 billion
enterprise dedicated to the related missions of medical
education, biomedical research, and high-quality patient
care. PENN Medicine consists of the University of Pennsylvania
School of Medicine (founded in 1765 as the nation’s
first medical school) and the University of Pennsylvania
Health System.
Penn’s School of Medicine is ranked #3 in the
nation for receipt of NIH research funds; and ranked
#4 in the nation in U.S. News & World Report’s
most recent ranking of top research-oriented medical
schools. Supporting 1,400 fulltime faculty and 700 students,
the School of Medicine is recognized worldwide for its
superior education and training of the next generation
of physician-scientists and leaders of academic medicine.
Penn Health System is comprised of: its flagship hospital,
the Hospital of the University of Pennsylvania, consistently
rated one of the nation’s “Honor Roll”
hospitals by U.S. News & World Report; Pennsylvania
Hospital, the nation's first hospital; Presbyterian
Medical Center; a faculty practice plan; a primary-care
provider network; two multispecialty satellite facilities;
and home health care and hospice.
|